The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature
Open Access
- 1 May 2014
- journal article
- Published by American Society of Hematology in Blood
- Vol. 123 (18) , 2893-2894
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomasNature Genetics, 2014
- Somatic RHOA mutation in angioimmunoblastic T cell lymphomaNature Genetics, 2014
- NIK Controls Classical and Alternative NF-κB Activation and Is Necessary for the Survival of Human T-cell Lymphoma CellsClinical Cancer Research, 2013
- Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomasHaematologica, 2012
- Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK–dependent integrin outside-in retractile signaling pathwayBlood, 2009
- Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphomaHaematologica, 2007
- Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-κBOncogene, 2002
- Rac Downregulates Rho ActivityJournal of Cell Biology, 1999